4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001992324-26-000006
EVP, CFO & CBO sold 8,224 shares at $89.84 ($738,844)
- EVP, CFO & CBO acquired 8,224 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Savitz Ryan EVP, CFO & CBO | 2026-04-09 | Option exercise 10b5-1 | +8,224 | $17.88 | $147,045 | 8,224 | D |
| Savitz Ryan EVP, CFO & CBO | 2026-04-09 | Sale 10b5-1 | −8,224 | $89.84 | $738,844 | 0 | D |
| Derivatives | |||||||
| Savitz Ryan EVP, CFO & CBO | 2026-04-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,224 | 71,776 | D | ||
| Open-market sales · 8,224 sh · avg $89.84 · $738,844 | |||||||
Loading xslF345X06/ownership.xml…